Storage Information Store unopened lyophilized peptide in a cool, dry environment
C20 fatty diacid modification enables once-weekly dosing via albumin binding
Patients should be educated about DKA symptoms (nausea, vomiting, abdominal pain, excessive thirst, frequent urination, fatigue, fruity-scented breath) and when to seek urgent care
For the newest retatrutide data in people with type 2 diabetes, severe obesity, and heart disease, read our July 2026 Retatrutide Phase 3 results guide
Real-world studies show an average weight loss of around 32 lbs., although results vary based on someones body size
Through it, neither we nor our external partners can receive personal information from you